Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Change in Account Payables (2016 - 2025)

Ingevity (NGVT) has disclosed Change in Account Payables for 11 consecutive years, with -$200000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables rose 99.59% to -$200000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $4.9 million, a 105.02% increase, with the full-year FY2024 number at -$63.4 million, down 334.25% from a year prior.
  • Change in Account Payables was -$200000.0 for Q3 2025 at Ingevity, up from -$1.9 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $41.4 million in Q2 2022 to a low of -$49.0 million in Q3 2024.
  • A 5-year average of -$768421.1 and a median of -$900000.0 in 2022 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: surged 1625.0% in 2022, then plummeted 688.89% in 2023.
  • Ingevity's Change in Account Payables stood at -$5.5 million in 2021, then changed by 0.0% to -$5.5 million in 2022, then crashed by 540.0% to -$35.2 million in 2023, then surged by 97.16% to -$1.0 million in 2024, then soared by 80.0% to -$200000.0 in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Change in Account Payables are -$200000.0 (Q3 2025), -$1.9 million (Q2 2025), and $8.0 million (Q1 2025).